CTL escape - progress in identifying therapeutic avenues to control HIV viraemia

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.4, Iss.3, 2000-06, pp. : 297-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody responses and virus escape: implications for HIV-1 vaccine and therapeutic design

By Tomaras Georgia Shen Xiaoying Greenberg Michael

Future Virology, Vol. 1, Iss. 1, 2006-01 ,pp. : 79-88

Future Medicine

Access to resources Recommend Favorite

Efavirenz/orlistat interaction: First report of an interaction, leading to recrudescence of HIV viraemia: case report

Reactions Weekly, Vol. 1, Iss. 1426, 2012-01 ,pp. : 21-22

Adis International

Access to resources Recommend Favorite

Editorial: New Avenues and Therapeutic Strategies for the Treatment of Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 23, Iss. 5, 2017-03 ,pp. : 667-668

Bentham Science Publishers

Access to resources Recommend Favorite

HIV Vaccines: Progress to Date

By > Andersen Christopher R. Kelleher Anthony D.

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 387-414

Adis International

Access to resources Recommend Favorite

Progress in the development of an HIV vaccine

By Tramont Edmund C Johnston Margaret I

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 37-45

Informa Healthcare

Access to resources Recommend Favorite